Cuschieri Sarah, Agius Steve, Souness Jorgen, Brincat Andre, Grech Victor
Faculty of Medicine & Surgery, University of Malta, Msida, Malta.
Chief Operations Officer, Mater Dei Hospital, Msida, Malta.
Health Sci Rev (Oxf). 2021;1:100001. doi: 10.1016/j.hsr.2021.100001. Epub 2021 Oct 4.
COVID-19 vaccines reduce morbidity and mortality, but mass vaccination faces multiple challenges leading to different vaccination rates in different countries. Malta, a small European country, has achieved a very rapid vaccination rollout. This paper presents a narrative review of Malta's vaccination strategy and its impact on the country's COVID-19 situation.
Data was obtained through a literature review of Maltese newspapers and from Malta's COVID-19 government dashboard. A comprehensive summary of vaccination operations was provided by Malta's COVID-19 vaccination team.
Malta comprised part of the European Commission joint procurement and obtained the maximum vaccines that were eligible from all manufacturers. Four tier priority population groups were set up, with both vaccine doses (where applicable) allocated and stored for each individual. Multiple hubs were set up to simultaneously administer first and eventually second doses accordingly. To date (August 9, 2021) 398,128 of the population are fully vaccinated and 405,073 received the first dose, with both morbidity and mortality declining progressively as vaccination coverage progressed.
Malta has successfully implemented a COVID-19 strategy that rapidly covered a substantial proportion of the population over a short period of time, with herd immunity reached by end of May 2021. Low population vaccination hesitancy and high vaccine doses availability were two major factors in this success.
新冠疫苗可降低发病率和死亡率，但大规模疫苗接种面临多重挑战，导致不同国家的疫苗接种率有所不同。马耳他是一个欧洲小国，其疫苗接种工作开展得非常迅速。本文对马耳他的疫苗接种策略及其对该国新冠疫情形势的影响进行了叙述性综述。
通过对马耳他报纸的文献回顾以及马耳他新冠疫情政府仪表盘获取数据。马耳他新冠疫苗接种团队提供了疫苗接种行动的全面总结。
马耳他参与了欧盟委员会的联合采购，从所有制造商处获得了符合资格的最大量疫苗。设立了四类优先人群组，为每个人分配并储存了两剂疫苗（如适用）。设立了多个接种中心，以便同时相应地接种第一剂疫苗并最终接种第二剂疫苗。截至2021年8月9日，该国398,128人已完全接种疫苗，405,073人接种了第一剂疫苗，随着疫苗接种覆盖率的提高，发病率和死亡率均逐渐下降。
马耳他成功实施了一项新冠疫苗接种策略，在短时间内迅速覆盖了相当比例的人口，到2021年5月底实现了群体免疫。低疫苗接种犹豫率和高疫苗供应量是取得这一成功的两个主要因素。
